Skip to main content

Nassar Investment Company LLC Recall: Salmonella. The firm was notified by the North Carolina Department of Agriculture that the product test positive for Salmonella.

United States

OngoingClass I

Company
Nassar Investment Company LLC
Product
Malazi 100% PURE SUDANESE SESAME Tahina G.W.: 1K.g UPC 6 224…
Recall date
April 30, 2026
Source
FDA

Reason for recall

Salmonella. The firm was notified by the North Carolina Department of Agriculture that the product test positive for Salmonella.

  1. - Recall initiated
  2. - Reported by source
Recalled products
Product description UPC Quantity Lot / code information
Malazi 100% PURE SUDANESE SESAME Tahina G.W.: 1K.g UPC 6 224011 088244 Produced by: AL-MALAZ COMPANY FOR TRADE AND INDUSTRY Piece No. 110-250 acres area Badr City - Egypt Not published in this source record 11cs/6/ 2lb bottles PROD: 31/12/2024 EXP: 30/12/2026

Distribution

  • Product was shipped to MI & NC.

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
H-0860-2026
Event ID
98923
Status
Ongoing
Classification
Class I
Company
Nassar Investment Company LLC
Product description
Malazi 100% PURE SUDANESE SESAME Tahina G.W.: 1K.g UPC 6 224011 088244 Produced by: AL-MALAZ COMPANY FOR TRADE AND INDUSTRY Piece No. 110-250 acres area Badr City - Egypt
Quantity
11cs/6/ 2lb bottles
Reason
Salmonella. The firm was notified by the North Carolina Department of Agriculture that the product test positive for Salmonella.
Recall initiation date
April 30, 2026
Report date
June 10, 2026
Classification date
Not published in this source record
Termination date
Not terminated as of this source record
Distribution pattern
Product was shipped to MI & NC.
UPC, lot, and code information
PROD: 31/12/2024 EXP: 30/12/2026
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Telephone
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Nassar Investment Company LLC

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Michigan 1
North Carolina 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.